Regeneron, Sanofi Get Positive CHMP Opinion for Du…

By Chris Wack

Regeneron Pharmaceuticals Inc. (REGN) and Sanofi (SNY) said Friday the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion for Dupixent dupilumab in a third indication.

Continue reading Finance News or read the source

This content was imported with an automated system, without human intervention.
You can report the removal of content by first reading our Legal Disclaimer